Biotech entity

Henrietta Lacks

Person

pharma is the sole category represented across all 1 tracked stories. Ben Crump is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Henrietta Lacks, all published on February 27, 2026.

Last mentioned: Feb 27, 2026

Entity pulse

Recent coverage · Henrietta Lacks

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Henrietta Lacks

pharma is the sole category represented across all 1 tracked stories. Ben Crump is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Henrietta Lacks, all published on February 27, 2026. Each carries 2 original sources on average.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Henrietta Lacks. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Novartis Settlement

    Novartis announces a confidential settlement with the Henrietta Lacks estate.

  2. Ultragenyx Settlement

    Ultragenyx settles with the estate over HeLa cell usage in gene therapy research.

  3. Thermo Fisher Settlement

    Thermo Fisher Scientific reaches a historic settlement with the Lacks family.

  4. First Major Lawsuit

    The Lacks estate files its first major lawsuit against Thermo Fisher Scientific.

  5. Mass Production

    HeLa cells are mass-produced and distributed globally, becoming a cornerstone of modern research.

  6. Cells Harvested

    Henrietta Lacks' cells are harvested without consent during cancer treatment at Johns Hopkins.

Stories mentioning Henrietta Lacks 1

Pharma Neutral

Novartis Settles With Henrietta Lacks Estate Over HeLa Cell Usage

Novartis has reached a confidential settlement with the estate of Henrietta Lacks, ending litigation over the unauthorized use of her 'immortal' HeLa cells. This marks the latest in a series of legal victories for the Lacks family against pharmaceutical giants that profited from cells taken without consent in 1951.

2 sources

Henrietta Lacks is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.